Skip to main content
    P

    Privia Health Group Inc (PRVA)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $24.99
    -0.27 (-1.07%)

    Market Cap: $3.14B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Privia Health Group Inc (PRVA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Privia Health Group (PRVA) has a market cap of $3.14B and an enterprise value of $2.69B. Its share count is up 3.88% from a year earlier. Its trailing P/E of 58.1x is above its 5-year median of 37.7x.

    Total Valuation

    Enterprise value is 14.23% below the market cap, as cash exceeds debt.

    Market Cap$3.14B
    Enterprise Value$2.69B
    Latest price (Nov 17, 2026)$24.99

    Key Dates

    The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 24, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.12% in the quarter ended Sep 30, 2026 and grew 3.24% a year over 2 years.

    Shares Outstanding127.54M
    Shares Change (YoY)+3.88%
    Shares Change (QoQ)+1.12%
    Share Count Growth (2Y CAGR)+3.24%

    Valuation Ratios

    Sales and book value multiples are 1.3x and 3.9x. Its year-end P/E ranged from 25.1x to 44.3x from 2022 to 2025.

    P/E Ratio58.1x
    Forward P/E86.0x
    P/S Ratio1.3x
    Forward P/S1.2x
    P/B Ratio3.9x
    P/TBV Ratio8.3x
    P/OCF Ratio29.0x
    PEG Ratio0.9

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 38.5x EBITDA.

    EV / Earnings69.7x
    EV / Sales1.1x
    EV / EBITDA38.5x

    Price Statistics

    The stock is up 6.57% over 52 weeks and trades 15.80% above its 50-day average.

    Beta (1Y)0.29
    52-Week Change+6.57%
    1-Month Change+11.36%
    3-Month Change+16.29%
    6-Month Change+7.30%
    5-Year Change-16.42%
    Total Return (1Y)+6.57%
    Total Return (3Y CAGR)+2.95%
    Total Return (5Y CAGR)-3.76%
    Return vs SPY (1Y)-3.52%
    Max Drawdown (1Y)-32.03%
    Max Drawdown (3Y)-33.57%
    Sharpe Ratio (1Y)0.24
    Correlation with SPY (1Y)0.12
    50-Day Average$21.58
    200-Day Average$22.69
    52-Week Range$18.91 to $28.82
    RSI (14 Days)68.1
    Average Volume (20 Days)1.37M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.63x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.63x
    Quick Ratio1.63x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is 4.73% over the last 12 months, against a 5-year average of -7.32%.

    Return on Equity (ROE)4.73%
    Return on Assets (ROA)2.47%
    ROE (5Y Average)-7.32%
    ROA (5Y Average)-4.70%
    ROIC (5Y Average)-18.63%
    Asset Turnover1.67x
    Receivables Turnover4.07x

    Taxes

    Income tax took 37.40% of pretax income over the last 12 months.

    Income Tax (TTM)$23.07M
    Effective Tax Rate37.40%

    Scores

    PRVA has an Altman Z-Score of 4.66, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score4.66
    Altman Z ZoneSafe
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $2.43B over the last 12 months is up 19.19% from the 12 months before.

    Revenue$2.43B
    Revenue Growth (YoY)+19.19%
    Gross Profit$2.16B
    Operating Income$51.01M
    Pretax Income$61.70M
    Net Income$38.62M
    EBITDA$71.10M
    Reported EPS (TTM)$0.43

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 52.29% of the $1.56B in total assets.

    Cash and Equivalents$446.28M
    Total Debt$0
    Net Cash$446.28M
    Net Cash Per Share$3.50
    Working Capital$425.20M
    Shareholder Equity$815.72M
    Book Value Per Share$6.40
    Tangible Book Value$384.63M
    Tangible Book Per Share$3.02
    Total Assets$1.56B
    Total Liabilities$690.80M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow$108.07M
    FCF Per Share$0.84
    Depreciation and Amortization$12.80M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 2.10%, against a 5-year average of -4.02%.

    Gross Margin88.73%
    Operating Margin2.10%
    Pretax Margin2.53%
    Net Margin1.59%
    EBITDA Margin2.92%
    Gross Margin (5Y Average)86.48%
    Operating Margin (5Y Average)-4.02%
    Net Margin (5Y Average)-3.39%

    Growth

    Revenue grew 16.10% a year over 3 years, and EPS 4.89% a year.

    Revenue Growth (3Y CAGR)+16.10%
    Revenue Growth (5Y CAGR)+21.04%
    EPS Growth (3Y CAGR)+4.89%
    EPS Growth (5Y CAGR)+43.10%
    FCF Growth (3Y CAGR)+51.02%
    FCF Growth (5Y CAGR)+33.32%
    Book Value Per Share Growth (2Y CAGR)+12.13%
    Tangible Book Per Share Growth (2Y CAGR)-2.71%

    Revenue and profit by year

    Dividends and Yields

    PRVA does not pay a dividend.

    Earnings Yield1.72%
    Buyback Yield-0.01%

    Peer Position

    Against 9 similar companies, PRVA has the highest P/E.

    P/E Ratio58.1x vs 29.6x median
    P/S Ratio1.3x vs 3.4x median
    Revenue Growth (Trailing 4 Quarters, YoY)+19.19% vs +6.91% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 14.46% and EPS growth at 30.96% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+14.46%
    EPS Growth Forecast (2Y CAGR)+30.96%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About PRVA

    What is PRVA's market cap?

    Privia Health Group has a market cap of $3.14B. Its enterprise value, which adds debt and subtracts cash, is $2.69B.

    What is PRVA's P/E ratio?

    Privia Health Group has a trailing P/E ratio of 58.1x and a forward P/E of 86.0x.

    How many shares of PRVA are outstanding?

    Privia Health Group has 127.54M shares outstanding. The count is up 3.88% from a year earlier.

    Does PRVA pay a dividend?

    No. Privia Health Group does not pay a dividend.

    How much debt does PRVA have?

    Privia Health Group has $0 of total debt and $446.28M of cash and equivalents, a net cash position of $446.28M.